Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer
Open accessThe DOI matches its Crossref record; 41 of the 46 references it cites were found in a registry or an index; 12 of the 47 sources its claims cite were checked for support.
Abstract
Prediagnostic CT findings suggestive of pancreatic cancer in scans obtained for unrelated reasons.
Overview
CoChat Summary
## TL;DR
This retrospective single-center study reviewed contrast-enhanced CT scans done within 1 year before pancreatic cancer diagnosis and found that 14 of 27 patients (51.9%) had suspicious findings that were overlooked. The main prediagnostic clues were a hypoattenuating mass, focal pancreatic duct dilatation, and distal parenchymal atrophy.
## Key findings
- Among 27 patients, 7 (33.3%) had normal pancreatic parenchyma and duct findings, while 20 (74.1%) had abnormal findings on retrospective review.
- Suspicious prediagnostic CT findings were seen in 14 patients (51.9%); these were all overlooked at the time of imaging.
- The most common suspicious findings were hypoattenuating mass-like lesions in 9 patients, focal pancreatic duct dilatation in 6, and distal parenchymal atrophy in 2; 3 patients had two findings simultaneously.
- The nine mass-like lesions had a median size of 1.2 cm, and the median time from CT to pancreatic cancer diagnosis was 6.6 months.
## Methods
- Retrospective study of patients diagnosed with pancreatic cancer at one hospital between January 2008 and December 2019; 27 patients who had contrast-enhanced abdominal or chest CT including the pancreas within 1 year before diagnosis and had no reported suspected pancreatic cancer lesion on the original CT report were included.
- Two board-certified abdominal radiologists independently reviewed prediagnostic CTs, classifying pancreatic parenchyma and duct findings and resolving disagreements by consensus.
- Main analysis was descriptive, with interobserver agreement assessed using Cohen’s kappa; no control group analysis was performed.
## Limitations
- The paper states this was a retrospective analysis with a small sample from a single center, so results may not reflect other institutions.
- The authors note that only patients who had CT before diagnosis were included, so the study cannot represent all pancreatic cancers detected incidentally.
- The paper says an appropriate control group could not be selected, so statistical analysis could not be performed; additionally, the CT-to-diagnosis interval varied from 1.9 to 12 months, making the prediagnostic CT findings less refined.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 0 Not valid · 19 Not checked · 43 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, main pancreatic duct dilatation and distal parenchymal atrophy are characteristic findings of early pancreatic cancer (9-12).”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Introduction
What the sources say
- Partly supportedcites [9] Takeshita K Kutomi K Haruyama T Imaging of early pancreatic cancer on multidetector row helical computed tomography. Br J Radiol 2010; 83: 823- 30. 10.1259/bjr/80905803 20442278 PMC3473757 sourceExperimental — accuracy not yet measured
The Discussion identifies main pancreatic duct stenosis or obstruction with distal duct dilatation as important for diagnosing early pancreatic cancer. The Results report pancreatic parenchymal atrophy in only two of eight patients and do not establish that it was distal or a characteristic finding. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [10] Hijioka S Ikari T Kamei A CT and MRI findings with contrast enhancement of small pancreatic adenocarcinoma in the late phase. Hepatogastroenterology 2007; 54: 389- 92. 17523281
- Not checked — no full text of the sourcecites [11] Ahn SS Kim MJ Choi JY Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol 2009; 19: 2448- 55. 10.1007/s00330-009-1422-6 19415290 source
- Not checked — no full text of the sourcecites [12] Prokesch RW Chow LC Beaulieu CF Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 2002; 224: 764- 8. 10.1148/radiol.2243011284 12202711 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The sensitivity for diagnosing small pancreatic cancers <10 mm in size by CT is 33–44% (5).”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Introduction
What the sources say
- Supportedcites [5] Hanada K Okazaki A Hirano N Diagnostic strategies for early pancreatic cancer. J Gastroenterol 2015; 50: 147- 54. 10.1007/s00535-014-1026-z 25501287 source
The section “Imaging of PC with tumors smaller than 10 mm” states that multidetector-row CT sensitivity for diagnosing tumors smaller than 10 mm ranged from 33% to 44%. The supplied passage does not give a page number. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among solid lesions found incidentally in the pancreas, pancreatic cancer is the most commonly found lesion, with a rate of approximately 31–34% (22).”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Discussion
What the sources say
- Supportedcites [22] Santo E Bar-Yishay I. Pancreatic solid incidentalomas. Endosc Ultrasound 2017; 6: S99- S103. 10.4103/eus.eus_72_17 29387702 PMC5774085 source
The SOLID PANCREATIC INCIDENTALOMA section reports pancreatic carcinoma in 31%–34% of incidentally identified solid lesions in retrospective resection series. The PANCREATIC CARCINOMA section calls it the most common cause of an incidentally identified solid lesion. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In three case series studies of localized main pancreatic duct structure without a detectable mass, 47–54% of cases were actually diagnosed with pancreatic cancer (31-33).”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Discussion
What the sources say
- Supportedcites [31] Kanno Y Koshita S Ogawa T Predictive Value of Localized Stenosis of the Main Pancreatic Duct for Early Detection of Pancreatic Cancer. Clin Endosc 2019; 52: 588- 97. 10.5946/ce.2019.018 31744269 PMC6900300 source
The Discussion reports that pancreatic cancer caused a single, localized main pancreatic duct stenosis in 47% of patients with no detectable mass or other pancreatic disease. The Methods identify this as a 19-patient study, supporting the lower end of the range for this source within the three-study citation group. (LLM, conf=0.92)
- Supportedcites [32] Miura S Kume K Kikuta K Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Tohoku J Exp Med 2020; 252: 63- 71. 10.1620/tjem.252.63 32879148 source
The Abstract (page not available) reports that 10 of 20 patients with a localized main pancreatic duct stricture and no identifiable mass had pancreatic cancer—50%, within the claimed 47–54% range. This paper supports one case series in the three-study citation, not the results of the other two; its patients had undergone pancreatectomy. (LLM, conf=0.89)
- Supportedcites [33] Kurita A Mori Y Someya Y High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer. Abdom Radiol (NY) 2021; 46: 4817- 27. 10.1007/s00261-021-03199-1 34223962 PMC8435518 source
The Patients section (page unavailable) describes a retrospective series of 37 patients with a localized main pancreatic duct stricture and no obvious mass. Results > Patient characteristics (page unavailable) reports confirmed malignancy in 20 of 37 patients, or 54%. This paper supports the upper end of the range as one of the three cited case series; it need not establish the other two series’ results. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Distal parenchymal atrophy was present in 4% of controls without pancreatic diseases (11,35) and in 7.1–15.8% of patients with benign main pancreatic duct stricture (32,34,36).”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Discussion
What the sources say
- Partly supportedcites [32] Miura S Kume K Kikuta K Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Tohoku J Exp Med 2020; 252: 63- 71. 10.1620/tjem.252.63 32879148 sourceExperimental — accuracy not yet measured
The Results section, “Focal parenchymal atrophy and fat replacement were associated with early pancreatic cancer” (page unavailable), reports the finding in 1 of 10 patients with benign MPD strictures (10%), which falls within the claimed range. It describes focal atrophy with fat replacement, however, not specifically distal parenchymal atrophy, and does not report the 7.1–15.8% range. (LLM, conf=0.84)
- Partly supportedcites [34] Yamao K Takenaka M Ishikawa R Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients. Diagnostics (Basel) 2020; 10: 445. 10.3390/diagnostics10070445 32630180 PMC7400308 sourceExperimental — accuracy not yet measured
Results §3.3 (page unavailable) reports partial parenchymal atrophy in 7.1% of patients with benign main pancreatic duct stenosis, supporting the lower end of the cited range. But Methods §2.4 distinguishes partial from upstream (distal-to-stenosis) atrophy, which Results §3.3 reports in 3.6%; this paper does not establish the 15.8% endpoint. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [36] Nakahodo J Kikuyama M Nojiri S Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ. Pancreatology 2020; 20: 1689- 97. 10.1016/j.pan.2020.09.020 33039293 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
39 more claims
Create a free account to see all 70 claims and to verify the 2 references still open.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 15
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Discussion
“All prediagnostic CT examinations were conducted for reasons unrelated to pancreatic cancer, and 59.3% of these CT scans were conducted in departments other than the gastroenterology department.”
§ Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer > Results > Characteristics of the patients
“The departments where the CT was conducted were the gastroenterology department for 11 (40.3%) patients and other departments [i.e., hematology-oncology (3 patients); infectious medicine, surgery, urology, and emergency medicine (2 patients for each department); endocrinology, rheumatology, and nephrology, pulmonology, and thoracic surgery (1 patient for each department)] for the remaining 16 (59.7%) patients.”
Citations
Cites
Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30974-0 · Cited by 2,559
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841 · cited 1×
“CT that is appropriate for the diagnosis of pancreatic cancer should be taken in the arterial phase (approximately 30 s after contrast injection) and portal venous phase (approximately 60–70 s after contrast injection), which are based on the pancreatic protocol (26).”
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659 · cited 1×
“An international consensus recommends conducting follow-up EUS or MRI annually in individuals with a family history or genetically high risk of pancreatic cancer (20).”
Risk factors for pancreatic cancer: a summary review of meta-analytical studies
Maisonneuve, P., & Lowenfels, A. B. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu240 · Cited by 439
Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Adenocarcinoma
Palazzo, L., Roseau, G., Gayet, B., Vilgrain, V., Belghiti, J., Fékété, F., & Paolaggi, J.-A. (1993) · Endoscopy · doi:10.1055/s-2007-1010273 · Cited by 403
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Lee, E. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7864 · Cited by 401 · cited 2×
“CT is the most widely used imaging modality for the diagnosis of pancreatic cancer, and it is helpful for determining the status of local and remote diseases and vascular invasion (8).”
Isoattenuating Pancreatic Adenocarcinoma at Multi–Detector Row CT: Secondary Signs
Prokesch, R. W., Chow, L. C., Beaulieu, C. F., Bammer, R., & Jeffrey, R. B. (2002) · Radiology · doi:10.1148/radiol.2243011284 · Cited by 337 · cited 4×
“In addition, main pancreatic duct dilatation and distal parenchymal atrophy are characteristic findings of early pancreatic cancer (9-12).”
InfluentialKauhanen, S. P., Komar, G., Seppänen, M. P., Dean, K. I., Minn, H. R., Kajander, S. A., Rinta-Kiikka, I., Alanen, K., Borra, R. J., Puolakkainen, P. A., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b2fafa · Cited by 317 · cited 1×
“The sensitivity and specificity of CT for pancreatic cancer diagnosis is 76–92% (23-25) and 67% (23), respectively.”
Multicenter study of early pancreatic cancer in Japan
Kanno, A., Masamune, A., Hanada, K., Maguchi, H., Shimizu, Y., Ueki, T., Hasebe, O., Ohtsuka, T., Nakamura, M., Takenaka, M., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2017.11.007 · Cited by 291 · cited 2×
“…asymptomatic; therefore, the processes by which early pancreatic cancer is diagnosed are regular follow-up examination of high-risk patients, medical examination in a healthy general population, and the incidental detection of pancreatic lesions on imaging tests conducted for other purposes (19).”
InfluentialModifiable and non-modifiable risk factors for pancreatic cancer: A review
Midha, S., Chawla, S., & Garg, P. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.022 · Cited by 281
Cited by
Gonda, M., Masuda, A., Kobayashi, T., Iemoto, T., Kakuyama, S., Ezaki, T., Ikegawa, T., Hirata, Y., Tsumura, H., Ogisu, K., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12557 · Cited by 21
Hidden in plain sight: commonly missed early signs of pancreatic cancer on CT
Ahmed, T. M., Chu, L. C. H., Javed, A. A., Yasrab, M., Blanco, A., Hruban, R. H., Fishman, E. K., & Kawamoto, S. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04334-4 · Cited by 14
Miki, M., Masuda, A., Takenaka, M., Shiomi, H., Iemoto, T., Tsumura, H., Tsujimae, M., Toyama, H., Sofue, K., Ueshima, E., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02149-0 · Cited by 11
Early detection of pancreatic cancer in the era of precision medicine
Ahmed, T. M., Kawamoto, S., Lopez-Ramirez, F., Yasrab, M., Hruban, R. H., Fishman, E. K., & Chu, L. C. H. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04358-w · Cited by 13
Pancreatic liposarcoma: A case report
(2025) · doi:10.3892/ol.2025.15014 · Cited by 1
“Although 2 cases of LPS were located in the pancreatic head, dilation of bile and pancreatic ducts was absent, likely because the tumor did not originate from the epithelial cells of pancreatic ducts (27).”
Metadata
- Authors
- Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S.
- Affiliations
- National Health Insurance Service Ilsan Hospital (KR)
- Corresponding author
- Park, Sumi
- Venue
- Journal of Gastrointestinal Oncology
- Publisher
- AME Publishing Company
- Published
- 2023-04
- Volume
- 14
- Issue
- 2
- Pages
- 1008-1018
- ISSN
- 2078-6891 (ISSN-L)
- 2219-679X
- PMC
- PMC10186522
- OpenAlex
- W4360985647
- Semantic Scholar
- e9812dfd03c1dd70c0140ed29b3db3a56557c478
- Cited by
- 10
- References
- 46
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Journal of Gastrointestinal Oncology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Health Insurance Service
- NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Keywords
- pancreatic cancer, early diagnosis, incidental finding, contrast-enhanced CT
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer. https://app.cochat.ai/papers/10.21037/jgo-22-863
- The paper
- Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S. (2023). Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-22-863
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.